Intas operates 10 formulation manufacturing facilities, of which eight are located in India with one each in U.K. and Mexico. It also operates two API and intermediate manufacturing facilities, each of which complies with the regulatory requirements in the jurisdictions in which it operates. Between them, these facilities have received approvals from various prominent international regulatory bodies, including U.S. Food and Drug Administration (USFDA).

All manufacturing facilities are well designed, sufficiently equipped and technically operated to deliver high quality products within defined cost and delivery schedules. These manufacturing facilities have flexibility to operate in various dosage forms with wide range of batch sizes. The Oncology facility is a world class facility that operates under global regulatory and safety standards. The Ahmedabad SEZ caters exclusively to the regulated markets in U.S. and Europe.

Manufacturing Facilities
Matoda		PharmEZ
Moraiya		Vatva
Dehradun		Gangtok
Sanand		Haverhill, UK
Mexico
API and Intermediate Facilities
Matoda Plant		Ankleshwar Plant